WHO ICTRP trial
SARS-CoV-2 (ORF1ab/N) Nucleic Acid Detection Kit (PCR-Fluorescent Probing)
ChiCTR2500112027 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500112027 |
|---|---|
| Public title | SARS-CoV-2 (ORF1ab/N) Nucleic Acid Detection Kit (PCR-Fluorescent Probing) |
| Scientific title | SARS-CoV-2 (ORF1ab/N) Nucleic Acid Detection Kit (PCR-Fluorescent Probing) |
| Primary sponsor | Guangdong Provincial Center for Disease Control and Prevention |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | 3 |
| Countries | China |
| Conditions | Novel Coronavirus Infection |
| Interventions | Gold Standard:Comparison reagents, Sanger sequencing;Index test:(ORF1ab/N) Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method) |
| Registration date | Nov 10, 2025 |
| Target size | Target condition:270;Difficult condition:315 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: